Who is sponsoring NCT05486442?

NCT05486442 is sponsored by Bahcesehir Cyprus University.

What drugs are being tested in NCT05486442?

Interventions in NCT05486442: ACT for weight-related experiential avoidance.

What condition does NCT05486442 study?

NCT05486442 studies Eating Behavior.

Is NCT05486442 still recruiting?

NCT05486442 is currently completed. Last updated 3 August 2022.

Last reviewed 2022-08-03 · How we verify

NCT05486442

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ACT for Weight-related Experiential Avoidance

Completed NA Last updated 3 August 2022

What this trial tests

NA trial testing ACT for weight-related experiential avoidance in Eating Behavior in 32 participants. Completed in 3 June 2022.

Timeline

4 March 2022

Primary endpoint
3 June 2022

3 June 2022

Quick facts

Lead sponsor	Bahcesehir Cyprus University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	32
Start date	4 March 2022
Primary completion	3 June 2022
Estimated completion	3 June 2022
Sites	1 location across Cyprus

Drugs / interventions tested

ACT for weight-related experiential avoidance

Conditions studied

Eating Behavior — all drugs for Eating Behavior →

Sponsor

Bahcesehir Cyprus University

Who can join

18 and older, any sex, with Eating Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate whether Acceptance and Commitment Therapy/Training would be helpful to reduce weight-related experiential avoidance among individuals who reported weight concern

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Eating Behavior

Currently open trials in the same condition.

NCT06551974 — INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders · NA · recruiting
NCT07348432 — The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes · recruiting
NCT06175988 — Visceral Adiposity, Vagal Tone and Food Preferences: a Pilot Study · recruiting
NCT06145009 — Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women · NA · recruiting
NCT06108128 — Food for Thought: Executive Functioning Around Eating Among Children · NA · recruiting

Other Bahcesehir Cyprus University trials

Trials by the same sponsor.

NCT05487872 — Mindfulness and Psychological Inflexibility · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05486442 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bahcesehir Cyprus University
Last refreshed: 3 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05486442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing